Table 1: Blood, proteins, glucose testing in P-series patient urine
samples (continued).
|
Parameters and diluted
urine samples |
Pre-RP urine samples |
Post-RP urine samples |
||||||
|
P10:Ui |
P12:Ui |
P13:Ui |
P:Um |
P10:Ui |
P12:Ui |
P13:Ui |
P:Um |
|
|
Cancer |
pros. |
pros. |
pros. |
pros. |
|
|
|
|
|
Stage |
Ⅱ |
Ⅱ |
Ⅱ |
5Ⅱ |
|
|
|
|
|
Gleason score |
8 |
7 |
6 |
7.2 |
|
|
|
|
|
Age |
62 |
78 |
66 |
62–77 |
|
|
|
|
|
Gender |
♂ |
♂ |
♂ |
♂ |
|
|
|
|
|
Sampling (5 days) |
(-34)– |
(-27)– |
(-27)– |
(-41)– |
1–29 |
1–22 |
1–22 |
1–33 |
|
Haemoglobin (Hb, blood)
(mg/dℓ) |
|
|
|
|
|
|
|
|
|
stock Ui/Um
(1st) |
0.06 |
0.00 |
0.00 |
0.50 |
0.00 |
0.30 |
0.00 |
0.02 |
|
10-1-diluted Ui/Um |
0.00 |
0.00 |
0.00 |
0.10 |
0.00 |
0.05 |
0.00 |
0.00 |
|
10-2-diluted
Ui/Um |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
10-3-diluted Ui/Um |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
Dilution for equi-occult
blood of 0.01 mg/dℓ or less Hb |
|
|
|
|
|
|
|
|
|
Extra-dilution rate |
6 |
1 |
1 |
50 |
1 |
30 |
1 |
2 |
|
Protein (mg/dℓ) |
|
|
|
|
|
|
|
|
|
stock Ui/Um
(1st) |
0.0 |
0.0 |
0.0 |
30.0 |
15.0 |
0.0 |
0.0 |
15.0 |
|
10-1-diluted Ui/Um |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
10-2-diluted
Ui/Um |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
10-3-diluted Ui/Um |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
Glucose (mg/dℓ) |
|
|
|
|
|
|
|
|
|
stock Ui/Um
(1st) |
0 |
0 |
0 |
0 |
0 |
400 |
0 |
30 |
|
10-1-diluted Ui/Um |
0 |
0 |
0 |
0 |
0 |
80 |
0 |
0 |
|
10-2-diluted
Ui/Um |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
10-3-diluted Ui/Um |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Pros.: Prostate; Hb: Haemoglobin.
Individual patient urine mixture (Ui)
of equal volumes of five urine samples from each patient with prostate cancer. P-series
urine mixture (P:Um) of equal volumes of 25 urine samples
from five patient P2, P5, P6, P8, and P9 on five different days
for each pre- and post-radical prostatectomy (post-RP). Abbreviation: pros.,
prostate. Ranges of patient 1st–5th sampling days are
shown, when day 0 is the ablative operation day of the patient.